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Abstract
Aim: The aim of this study was to evaluate the potential possibility of crude larval and recombinant (rHcp26/23) antigens
of Haemonchus contortus for immunization to control sheep hemonchosis.
Materials and Methods: A total of 21 lambs were divided into five groups. Lambs were immunized with larval and
recombinant (rHcp26/23) proteins at day 0 and day 14 and after that challenged with 5000 infective larvae of H. contortus
on day 42. An unvaccinated positive control group was challenged with L3 in the meantime. An unvaccinated negative
control group was not challenged.
Results: Fecal egg count reduction taking after challenge for rHcp26/23 and larval antigens was 92.2% and 38.2%,
respectively, compared with the positive control group. Vaccine incited protection in rHcp26/23 and larval immunization
was reflected in significant (p<0.05) decreases in worm burden; 59.9% and 40.1%, respectively.
Conclusion: Recombinant rHcp26/23 vaccine induced a partial immune response and had immune-protective effect against
sheep hemonchosis.
Keywords: antigen, Haemonchus contortus, immunization, larval, rHcp26/23, sheep.
Introduction

Lambs are infected by an assortment of gastrointestinal nematodes. Their effects range from slight to
lethal, depending on numerous elements, for example,
the site and degree of infection, method of feeding of
the nematode, and the nourishing and physiological
status of the host [1,2]. Haemonchus contortus feeds
on blood obtained by damaging the abomasal mucosa
resulting in mild anemia to mortality, especially in
younger animals [3].
The control of nematode parasite is dependent on
chemical antihelminthic treatment and pastures management. Moreover, parasite strains resistant to these
antihelminthic drugs had been on the increase [4-6].
Today, vaccination control measures are viewed as
the most ideal instruments [7,8]. Numerous studies concentrated on the identification and characterization of immunogenic antigens of H. contortus,
and their capability to incite protective immunity by
Copyright: Kandil, et al. Open Access. This article is distributed under
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immunization. Among the most encouraging antigens, crude, larval, and the somatic antigen p26/23
are usually utilized [2,7-10]. Results from vaccination trials have differed in protection levels from
32.2% to 90% decrease in parasite egg shedding and
61-78% reductions in worm burden in the abomasa
of immunized sheep [7,11,12]. The protein fraction
p26/23 from adult worms was immunoprotective in
lambs challenged with H. contortus [12]. As of late,
the substance of this fraction protein has been analyzed, and the real protein present has been purified,
immunolocalized, and mostly sequenced, cloned and
expressed [13,14]. What’s more, the two antigens
H-gal-GP and H11 isolated from intestinal cells of
H. contortus have continually protection to a degree
which would surpass antihelmintic treatment administration (i.e., >80% adequacy in >80% of the herd;
and which would in this way be financially helpful.
Native H-gal-GP and H11 have each been appeared to
diminish fecal egg counts (FEC) by more than 90% in
immunized sheep and, when utilized as a part of mix;
their impact in a controlled field trial was very viable
for grazing Merino sheep [15].
In this study, two unique antigens crude larval
antigen and recombinant protein (rHcp26/23) were
prepared and after that characterized by immunoblot.
The goal of this study was to compare the immune
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response evoked by vaccination with the prepared
antigens.
Materials and Methods
Ethical approval

This study was approved by Medical Research
Ethics Committee (National Research Centre, Egypt)
under registration number (16050). The experiments
were conducted in accordance with the guidelines laid
down by the International Animal Ethics Committee
and in accordance with local laws and regulations.
Sample collection

H. contortus adult worms were obtained from
abomasa of slaughtered sheep at different abattoirs
in Egypt. L3 were obtained from cultured eggs from
female worms according to Soulsby [16]. Identification
of the collected worms and L3 was done according
to Whitlock [17]. The collected L3 was washed with
phosphate-buffered saline (PBS) and stored at 4°C for
infection purposes and challenge trials.
Crude L3 antigen of H. contortus

Balady lambs were housed in a hygienic isolated
pen and fed a balanced ration, offered fresh water, parasitologically examined for eggs per gram (EPG) to
ensure that it was free from any helminthes, and kept
under observation for 30 days to acclimate before the
experiment. Two balady lambs 2-3 months of age
were experimentally infected with 5000 L3. Eggs were
obtained from infected sheep after 21 days of infection.
L3 were obtained from fecal culture and then baermannization. Preparation of antigen was done according to
Alunda et al. [18]. In brief, 100 g of feces was weighed
and incubated for 2-3 weeks at room temperature.
During this time, it was regularly checked for desiccation, moistened if necessary, and ventilated for 1 h/day.
After incubation, L3 was harvested by baermanization
for 24 h. The sediment containing the accumulated L3
larvae was obtained. The total protein content was estimated by Lowry protein assay to determine the total level
of protein in the antigen according to Lowry et al. [19],
and the L3 antigen was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and western blotting (WB) using pooled sera from
experimentally infected positive control lambs according to Laemmli [20] and Towbin et al. [21]. Concisely,
L3 antigen was resolved using 10% polyacrylamide gel
under reducing conditions. After electrophoresis, one
gel was stained with Coomassie brilliant blue R-250
dye, and the other was transferred to 0.45 nitrocellulose
membrane and blocked for 1 h in 1% dry skimmed milk
dissolved in PBS pH 7.2, then probed overnight against
experimentally infected positive and negative control
lamb sera at 1:100 in tris-buffered saline (TBS) with
0.5% bovine serum albumin (BSA). The nitrocellulose
strips were incubated with anti-sheep immunoglobulin
G (IgG) (whole molecule) peroxidase antibody produced in donkey (Sigma-Aldrich, USA) in 0.5% BSA/
TBS buffer for 1 h at dilution 1:1000. The reactive bands
Veterinary World, EISSN: 2231-0916

were developed by incubation of the blot in the substrate
solution (1-chloronaphthol [Sigma-Aldrich, USA], one
tablet [30 mg/1 ml methanol] added to 10 ml methanol,
39 ml TBS, and 30 µl 30% H2O2) for 5 min.
Recombinant somatic H. contortus protein 26/23
(rHcp26/23)

Adult male H. contortus was used in an RNA
extraction kit protocol (Qiagen, Germany) according
to Garcıa-Coiradas et al. [14]. Reverse transcriptase
polymerase chain reaction (PCR) was carried out in
two independent steps: Synthesis of cDNA (1st strand
cDNA Synthesis Kit, AMV, Roche) using hexanucleotide random primers with BamHI and HindIII
restriction targets:
F BamHI (5\GGATCCGCAGGACTGTTCGC
ACAT3\) and R HindIII (5\AAGCTTTCAGTCTTT
CGCGGACTTG3\).
The PCR amplification included denaturalization
for 3 min at 94°C, followed by 30 cycles (95°C, 1 min)
with one annealing elongation step at 71°C for 1 min
and, finally, an elongation step at 72°C for 10 min. PCR
was carried out in a PTC-100 (MJ Research Inc.). The
resulting fragment was cloned in the vector pGEM-T
(Promega), and the construct was used to transform
Escherichia coli XL2-blue. Positive bacterial colonies were identified by PCR employing the primers;
SP6 (5\ATTTAGGTGACACTATAGAA3) and T7
(5\TAATACGACTCACTATAGGG3\).
Minipreps
were prepared with PCR-positive colonies (QIAprep
Spin Miniprep Kit Qiagen).
The insert was cloned in the expression vector pQE30 (QIAexpress Vector, Qiagen), and the
construct was employed to transform E. coli M15
(Qiagen). Positive bacterial colonies were identified
by PCR employing the primers as follows: for the plasmid FpQE (5\GAATTCATTAAAGAGGAGAAA3\),
for the insert R (5\TCAGTCTTTCGCGGACTTG3\).
The nucleotide sequence of PCR products and the positive bacterial clones in E. coli XL2-blue were determined by the Animal Health Research Institute. The
expression of the recombinant protein (rHcp26/23)
was carried out with a PCR positive clone of E. coli
cultured in Luria broth medium. Cell pellets from cultures were resuspended, and protein was solubilized in
both denaturing and nondenaturing conditions. In the
purification under denaturing condition, the recombinant His6tagged p26/23 was purified in 10 cm × 1 cm
columns (BioRad) of Ni-NTA agarose (Qiagen).
Purification of the recombinant protein was carried
out and was analyzed by SDS-PAGE and WB [20,21]
using pooled sera from vaccinated lambs with the
fraction p26/23. The protein markers used were protein marker M1: Genscript, Cat. No. M00505 and protein marker M2: Genscript, Cat. No. MM0908.
Vaccine protocol

The formulated crude larval and recombinant
H. contortus vaccines were safety tested in rabbits
before vaccination trails [22], and shown to be safe.
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Twenty one, 3-month-old helminthes-free lambs were
obtained locally and housed in an isolation facility.
The animals did not graze with their mothers, and
FEC was performed quantitatively using a McMaster
technique [16] to ensure that it was helminthes-free.
Lambs were distributed in a stratified manner (by
live weight) onto 5 experimental groups. Group 1
(n=5), immunized with rHcp26/23; Group 2 (n=5),
immunized with crude L3 antigen; Group 3 (n=5),
received only adjuvant, challenged control; Group 4
(n=3), challenged only, positive control; Group 5
(n=3), unvaccinated and unchallenged negative control. Lambs from Groups 1 and 2 received immunizing injections (intramuscular and subcutaneous
in the inner thigh and hind legs) on days 0 and 14.
The first injection (100 µg protein) was administered
in 1 mL Freund’s complete adjuvant (Sigma-Aldrich,
USA) and the second injection was administered in
1 mL Freund’s incomplete adjuvant (Sigma-Aldrich,
USA). On day 42, Groups 1-4 were challenged with
5000 H. contortus L3 [9]. Sera from different animals’
group were weekly collected from 0 days till end of
the experiment to evaluate the sero-conversion of the
animals.
Evaluation of vaccines

FEC and worm burden

FEC was performed by the McMaster technique [16] at 2 days intervals from 17 days after challenge infection until the end of the study. Sheep were
euthanized and slaughtered humanely at 50 days after
challenge for abomasal worm count determination.
Abomasa were immediately removed, opened and the
contents collected in a container. The empty abomasa
were washed thoroughly with warm 0.85% NaCl
solution to remove adhering worms and subsequently
soaked thoroughly, and the washing was sampled.
Worm counts were made on 1/50 aliquots on both
washing and abomasal content.
Immunological assay

Humoral immune response (estimation of H. contortus serum antibody level using enzyme-linked
immunosorbent assay [ELISA] technique) was done
according to Kandil et al. [23]. Each prepared antigen
was used to test its respective vaccinated group with
the positive and negative control groups from zero
days to the end of the experiment. Briefly, the wells
were coated with 100 µl of each diluted antigens; L3
and rHcp26/23 at the concentration of 0.2 µg/well in
carbonate-bicarbonate buffer, pH 9.6 and incubated
for 1 h at 37°C then incubated overnight at 4°C. After
blocking, 100 µl/well of diluted serum at 1:200 was
added as duplicate, and the plates were incubated for
1.5 h at 37°C. Then, 100 µl/well of conjugate; antisheep IgG (whole molecule) peroxidase antibody
produced in donkey (Sigma-Aldrich, USA) diluted
at 1:1000 in diluting buffer was added and incubated
for 1 h at 37°C. The plates were washed extensively
with washing buffer. 100 µl/well of substrate solution
Veterinary World, EISSN: 2231-0916

(20 mg of O, phenylenediamine [Alfa Aesar, UK] was
dissolved in 50 ml substrate buffer, pH 5 and 25 µl
30% H2O2) was added to all wells and the plates were
incubated 10 min at 37°C. The optimum color development was stopped by addition of 100 µl of stopping buffer (5% SDS) to each well. OD was read at
wavelength of 450 nm with an ELISA reader (BioTek, Inc., ELx, 800 UV). The sera were considered
to be positive when the absorbance values were more
than the cutoff value. The cutoff value was calculated
as mean value plus 3 times the standard deviation of
optical density value of negative control sera.
Statistical analysis

Data were statistically analyzed by ANOVA that
was used to test for differences between the immunized and control means, and Duncan’s test was used
to separate means at stated level (p<0.05) using SPSS
computer program.
Results
Evaluation of the crude L3 and recombinant somatic
protein rHcp26/23 H. contortus antigens

Electrophoretic profile of the L3 antigen showed
multiple fractions in both high and low molecular
weights (Figure-1). L3 antigen gave 13 protein bands
with different molecular weights (187, 112, 88, 76, 66,
53, 45, 32, 28, 21, 17, 14, and 10 kDa). The immuneblot reaction showed that 7 (100, 75, 66, 35, 34, 32,
and 28 kDa) antigenic bands of crude L3 antigen were
recognized using positive sera (Figure-2).
The electrophoretic and blotting analysis
revealed that the rHcp26/23 protein was identified at
26 kDa using anti-His antibody (Figure-3).
Immunological assay

Antibody level achieved most elevated values
for rHcp26/23 and L3 on weeks 6 and 5, respectively,
and stayed high until the end of the study. On contrary,
antibodies levels in sera of adjuvant, non-immunized
infected, and non-infected controls were low (Figure-4).

Figure-1: Sodium dodecyl sulfate polyacrylamide gel
electrophoresis of crude L3 antigen of Haemonchus
contortus. MW: Unstained broad range protein marker,
Promega. L3: Crude L3 antigen of H. contortus.
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In adjuvant and non-immunized infected controls, the first eggs were detected on day 22 after L3
challenge. The counts increased gradually during
the sampling period, reaching peak levels at 40 days
post-challenge (Figure-5). Whereas in rHcp26/23
and L3 immunized groups, positive egg counts were
observed from day 32 to 28, respectively. From this
day onward, the FEC was lower in the immunized
sheep than in the non-immunized sheep. FEC ranged
from 750 to 7000 EPG for the sheep immunized with
rHcp26/23 and 750-9900 EPG for those immunized
with L3 antigen. FEC in non-immunized infected
controls ranged from 3800 to 13800 EPG. At day
50, mean EPG was reduced in the groups immunized

with rHcp26/23 (800±72) and L3 (6300±504) contrasted with the control (10,200±816). Accordingly,
the mean FEC for immunized groups was reduced by
92.1% with rHcp26/23 and 38.2% with L3 antigen, at
day 50. This study revealed that there was a significant (p<0.05) reduction in mean FEC for rHcp26/23
immunized group compared to the control group.
Vaccine incited protection in rHcp26/23 and
L3 immunized groups was reflected in significant
reductions in worm burden; 59.9% (p<0.05) and
40.1% (p<0.05), respectively, contrasted with the
non-vaccinated infected control group. Less worms
were recovered from the group vaccinated with
rHcp26/23 (297.7±32.8) contrasted with the control
(742.8±66.9) or the L3 immunized group (445.3±57.9).
Discussion

In this study, the prospective efficacy of recombinant rHcp26/23 of H. contortus and its crude L3
antigens to protect against homologous infection was
investigated in sheep. The results proved that sheep
was partially protected with reductions in FEC and
abomasal worm burden for rHcp26/23 immunized
group (92.1% and 59.9%, respectively) and minor
reductions were achieved with L3 antigen (38.2% and
40.1%, respectively). The immunized groups recorded
higher anti-Haemonchus antibodies levels after challenge infection compared with their non-immunized

Figure-2: Immunoblotting analysis of crude L3 antigen of
Haemonchus contortus. M: Unstained broad range protein
marker, Promega. 1: Pooled sera from experimentally
infected positive sheep against crude L3 antigen of
H. contortus. 2: Negative sheep serum.

Figure-4: Appearance of anti-Haemonchus antibodies in
sera of recombinant protein rHcp26/23 and L3 immunized
sheep compared to control groups at different intervals
postchallenge.

Figure-3: Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and Western blot analysis
of recombinant somatic Haemonchus contortus protein
26/23 (rHcp26/23). MW of SDS-PAGE: Genscript, Cat. No.
M00505. rHcp26/23: Recombinant somatic H. contortus
protein 26/23 antigen. MW of WB: Genscript, Cat. No.
MM0908. rHcp26/23: Recombinant somatic H. contortus
protein 26/23 antigen against pooled sera from vaccinated
lambs with the fraction rHcp26/23.
Veterinary World, EISSN: 2231-0916

Figure-5: Mean fecal egg count (eggs per gram of feces)
for recombinant protein rHcp26/23 and L3 immunized
sheep compared to control groups at different intervals
postchallenge.
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groups. Results demonstrated that little amounts of
two somatic peptides (rHcp26/23) inspired in partially
protective response against H. contortus challenge
in sheep. The level of protection accomplished with
rHcp26/23 was similar to that reported by Jasmer and
McGuire [24] utilizing gut protein from H. contortus in
goat and those accomplished in sheep utilizing excretory-secretory proteins [25], purified antigen from
larvae [7], or diverse adult membrane antigen [24].
Jasmer and McGuire [24] showed that gut antigens
communicated in adult H. contortus were available in
L3 might be imperative. Experiments described here
were not designed to test whether pre-adult parasite
stages were affected by immunity to adult gut antigens. Nonetheless, results suggest this is conceivable
since both third- and fourth-stage larvae are tissue
dwelling. The presentation of protective gut antigens
expressed in these tissue stages could stimulate good
immune responses in vaccinated animals when they are
exposed to natural challenge [26]. Therefore, selecting
specific antigens expressed in the adult gut and larvae
may be an important strategy in vaccine development.
Likewise, Coyne and Brake [27] revealed the potential
possibility of propagating parasite-derived cell populations in an in vitro tissue culture environment in a way
that holds their capacity to express immunoprotective
antigenic fractions. Understanding of experimental
findings cleared that sheep with the best antigen-specific humoral immune responses (IgG titre 1/3125)
also showed a level of lessened abomasal H. contortus hatchlings loads (60% decrease) [27]. The rates
of egg and worm diminishments were additionally
equivalent to those got by Piedrafita et al. [7], Fawzi
et al. [8], and Fawzi et al. [12] utilizing the same low
molecular weight peptides from H. contortus in sheep.
On contrary, Garcıa-Coiradas et al. [14] reported that
regardless of the strong immune response elicited by
the immunization of lambs with the recombinant protein (rHcp26/23) no protection against the H. contortus
challenge was found. They recommended numerous
explanations behind the lacking denaturalization of
the recombinant proteins and glycosylation of the
defensive antigens. Whereas, in this study, complete
purification of the expressed protein was done since
carbohydrate moieties might mask the potential protective responses [28].
In this study, the decrease of aggregate worms
and FEC in both vaccinated groups demonstrated an
alternate pattern with the ELISA optical densities of
sera. This may be attributed to the poor antigenicity
of somatic antigen contrasted with larval and different
antigens [23]. Vaccination did not totally kill nematodes from immunized animals but rather it could be
proficient to lessen field contamination and thus the
level of reinfection. The greater value of vaccines
might be in diminishing field pollution than killing the
nematodes in the host [12].
Finally, vaccinations are essential part of a group
well-being administration program. The vaccination
Veterinary World, EISSN: 2231-0916

program ought to kill worms at the top of infection
and avoid reinfection of field during high-risk periods.
Two vaccinations are prescribed, from the author’s
feeling, toward the start of the dry season and two
vaccinations toward the start of the rainy season. The
interim between the first and second vaccinations
ought to be 2-3 weeks. The vaccination toward the
start of the dry season is done to dispense with current
parasite burden, empowering lambs to better adapt to
the dietary stress during the dry season. A vaccination
before the rainy season will forestall contamination of
fields at a time when conditions are getting to be positive for egg and larval development.
Conclusion

The potential of recombinant protein rHcp26/23
of H. contortus and crude L3 protein to protect against
homologous infection was investigated in sheep. The
findings suggested that sheep was partially protected
with reductions in FEC and abomasal worm burden
for rHcp26/23 immunized sheep with lower reductions achieved with L3 antigens.
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